BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 9500620)

  • 1. Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow.
    Khanna A; Steptoe RJ; Antonysamy MA; Li W; Thomson AW
    Transplantation; 1998 Feb; 65(4):479-85. PubMed ID: 9500620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Flt-3 ligand on donor-derived antigen presenting cells and alloimmune reactivity in heart graft recipients given adjuvant donor bone marrow.
    Khanna A; Antonysamy MA; Subbotin VM; Steptoe RJ; Li W; Rudert WA; Thomson AW
    Transpl Immunol; 1998 Dec; 6(4):225-34. PubMed ID: 10342736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
    Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
    Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients.
    Antonysamy MA; Steptoe RJ; Khanna A; Rudert WA; Subbotin VM; Thomson AW
    J Immunol; 1998 Apr; 160(8):4106-13. PubMed ID: 9558122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
    Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
    J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus.
    Iyengar AR; Bonham CA; Antonysamy MA; Subbotin VM; Khanna A; Murase N; Rao AS; Starzl TE; Thomson AW
    Transplantation; 1997 May; 63(9):1193-9. PubMed ID: 9158008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.
    Fu F; Li Y; Qian S; Lu L; Chambers F; Starzl TE; Fung JJ; Thomson AW
    Transplantation; 1996 Sep; 62(5):659-65. PubMed ID: 8830833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival.
    Takayama T; Kaneko K; Morelli AE; Li W; Tahara H; Thomson AW
    Transplantation; 2002 Jul; 74(1):112-9. PubMed ID: 12134108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
    Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
    Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal donor bone marrow is superior to Flt3 ligand-mobilized bone marrow in prolonging heart allograft survival when combined with anti-CD40L (CD154).
    Hackstein H; Wang Z; Morelli AE; Kaneko K; Takayama T; Colvin BL; Bein G; Thomson AW
    Am J Transplant; 2002 Aug; 2(7):609-17. PubMed ID: 12201361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor.
    Lu L; Rudert WA; Qian S; McCaslin D; Fu F; Rao AS; Trucco M; Fung JJ; Starzl TE; Thomson AW
    J Exp Med; 1995 Aug; 182(2):379-87. PubMed ID: 7629500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement for early donor cell chimerism during prolonged survival of murine skin allografts.
    Masli S; De Fazio SR; Gozzo JJ
    Transplantation; 2000 Apr; 69(8):1667-75. PubMed ID: 10836379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microchimerism, dendritic cell progenitors and transplantation tolerance.
    Thomson AW; Lu L; Murase N; Demetris AJ; Rao AS; Starzl TE
    Stem Cells; 1995 Nov; 13(6):622-39. PubMed ID: 8590864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506.
    Iwata H; Kitagawa S; Sato S; Kosugi A; Hirose H; Hamaoka T; Shearer GM; Fujiwara H
    Transplantation; 1993 Jul; 56(1):173-80. PubMed ID: 7687396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between allograft survival and chimeric state after bone marrow infusion in rat small bowel transplantation.
    Bakonyi Neto A; Ricordi C; Feo CF; Porcu A; Misiakos EP; Gandia C; Ruiz P; Bertho M; Carreno M; Esquenazi V; Miller J; Tzakis AG
    Pediatr Transplant; 1999 Feb; 3(1):67-73. PubMed ID: 10359034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.